We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from other web pages that is not governed by us.
Course catalog
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
To support the C-CHANGE guideline for the role of SGLT2i in patients with heart failure.
To support the C-CHANGE guideline for the role of SGLT2i in patients with heart failure.
To support the updated Diabetes Canada guideline, part of the C-CHANGE CPG, for the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes
To support the updated Diabetes Canada guideline, part of the C-CHANGE CPG, for the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes